Cervoni P et al. |
Evidence for the lack of interaction between (+/-)-1-O-octadecyl-2-acetylglyceryl-3-phosphorylcholine and alpha-adrenoceptors in vivo and in vitro. |
1984 |
Br. J. Pharmacol. |
pmid:6091835
|
Mendlovic F et al. |
Possible involvement of cyclooxygenase products in the actions of platelet-activating factor and of lipoxygenase products in the vascular effects of epinephrine in perfused rat liver. |
1984 |
Biochem. Biophys. Res. Commun. |
pmid:6435614
|
Fouque F and Vargaftig BB |
Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation. |
1984 |
Br. J. Pharmacol. |
pmid:6439269
|
Karlsson G and Pipkorn U |
Effect of disodium chromoglycate on changes in nasal airway resistance induced by platelet activating factor. |
1984 |
Eur. J. Clin. Pharmacol. |
pmid:6439565
|
Sänze JU et al. |
On the nature of the vasoreactivity depressing factor (VDF) in inflammation and anaphylaxis in the rat and mouse. |
1984 |
Biomed. Biochim. Acta |
pmid:6440544
|
Camussi G et al. |
Effect of platelet activating factor on guinea-pig papillary muscle. |
1984 |
Experientia |
pmid:6086382
|
Sills RH |
Thrombotic thrombocytopenic purpura. I. Pathophysiology and clinical manifestations. |
1984 |
Am J Pediatr Hematol Oncol |
pmid:6442830
|
Lartigue-Mattei C et al. |
Pharmacokinetic study of 3H-labelled PAF-acether II. Comparison with 3H-labelled lyso-PAF-acether after intravenous administration in the rabbit and protein binding. |
1984 |
Agents Actions |
pmid:6532184
|
Kulikov VI et al. |
[Incorporation of 1-0-alkyl-2-acetyl-sn-glycerol-3-phosphocholine into human plasma lipoproteins in vitro. Effect of the lecithin:cholesterol acyltransferase activity of plasma]. |
1984 |
Biokhimiia |
pmid:6542803
|
Nagata K et al. |
[Thrombotic thrombocytopenic purpura (TTP) with a remission following splenectomy after the failure of antiplatelet therapy and plasmapheresis]. |
1984 |
Rinsho Ketsueki |
pmid:6542941
|
Pirotzky E et al. |
PAF-acether-induced plasma exudation in rat skin is independent of platelets and neutrophils. |
1984 |
Microcirc Endothelium Lymphatics |
pmid:6546141
|
Bussolino F et al. |
Platelet-activating factor phosphatidate, but not platelet-activating factor, is a powerful calcium ionophore in the human red cell. |
1984 |
Cell Calcium |
pmid:6549153
|
Pirotzky E et al. |
Biosynthesis of platelet-activating factor. VI. Precursor of platelet-activating factor and acetyltransferase activity in isolated rat kidney cells. |
1984 |
Lab. Invest. |
pmid:6492758
|
Smith RJ et al. |
Stimulation of the human neutrophil superoxide anion-generating system with 1-O-hexadecyl/octadecyl-2-acetyl-sn-glyceryl-3- phosphorylcholine. |
1984 |
Biochem. Pharmacol. |
pmid:6324816
|
Buxton DB et al. |
Stimulation of hepatic glycogenolysis by acetylglyceryl ether phosphorylcholine. |
1984 |
J. Biol. Chem. |
pmid:6693418
|
Shukla SD and Hanahan DJ |
Acetylglyceryl ether phosphorylcholine (AGEPC; platelet-activating factor)-induced stimulation of rabbit platelets: correlation between phosphatidic acid level, 45Ca2+ uptake, and [3H]serotonin secretion. |
1984 |
Arch. Biochem. Biophys. |
pmid:6465886
|
Doebber TW et al. |
Platelet activating factor intravenous infusion in rats stimulates vascular lysosomal hydrolase secretion independent of blood neutrophils. |
1984 |
Biochem. Biophys. Res. Commun. |
pmid:6517949
|
Heinrich J and Zimmermann RE |
Compound 48/80 is a potent inhibitor of human platelet aggregation antagonizing the calmodulin-dependent platelet reaction in vitro. |
1984 |
Thromb. Res. |
pmid:6523451
|
Oxholm P et al. |
Lack of evidence for human lymphokines with thrombocyte aggregating activity. An in vitro study. |
1984 |
Allergy |
pmid:6528957
|
Hwang SB et al. |
Effects of nonsteroid antiinflammatory drugs on the specific binding of platelet activating factor to membrane preparations of rabbit platelets. |
1984 |
Thromb. Res. |
pmid:6429890
|
Colditz IG and Movat HZ |
Kinetics of neutrophil accumulation in acute inflammatory lesions induced by chemotaxins and chemotaxinigens. |
1984 |
J. Immunol. |
pmid:6470487
|
Patterson R et al. |
Airway responses to sequential challenges with platelet-activating factor and leukotriene D4 in rhesus monkeys. |
1984 |
J. Lab. Clin. Med. |
pmid:6470563
|
Ludwig JC et al. |
Modulation of platelet-activating factor (PAF) synthesis and release from human polymorphonuclear leukocytes (PMN): role of extracellular Ca2+. |
1984 |
Arch. Biochem. Biophys. |
pmid:6430234
|
Söling HD et al. |
Acetylcholine-like effects of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine ('platelet-activating factor') and its analogues in exocrine secretory glands. |
1984 |
Eur. J. Biochem. |
pmid:6207023
|
Pipkorn U et al. |
Effect of platelet activating factor on the human nasal mucosa. |
1984 |
Allergy |
pmid:6703263
|
Lüthje J and Ogilvie A |
Diadenosine triphosphate (Ap3A) mediates human platelet aggregation by liberation of ADP. |
1984 |
Biochem. Biophys. Res. Commun. |
pmid:6704102
|
Clare KA and Scrutton MC |
The role of Ca2+ uptake in the response of human platelets to adrenaline and to 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor). |
1984 |
Eur. J. Biochem. |
pmid:6705791
|
Kumar R et al. |
A facile route to semi-synthesis of acetyl glycerylether phosphoethanolamine and its choline analogue. |
1984 |
J. Lipid Res. |
pmid:6707528
|
Archer CB et al. |
Synergistic interaction between prostaglandins and PAF-acether in experimental animals and man. |
1984 |
Prostaglandins |
pmid:6203139
|
Schlondorff D et al. |
Effect of platelet-activating factor and serum-treated zymosan on prostaglandin E2 synthesis, arachidonic acid release, and contraction of cultured rat mesangial cells. |
1984 |
J. Clin. Invest. |
pmid:6423667
|
Vargaftig BB et al. |
[Platelet aggregation and PAF-acether. Pharmacologic interference]. |
1984 |
J Pharmacol |
pmid:6374298
|
Ito S et al. |
Hyperacute renal allograft rejection in the rabbit. The role of platelet-activating factor and of cationic proteins derived from polymorphonuclear leukocytes and from platelets. |
1984 |
Lab. Invest. |
pmid:6379289
|
Bult H et al. |
Complement derived factors and prostacyclin formation by rabbit isolated peritoneum and cultured mesothelial cells. |
1984 |
Agents Actions Suppl. |
pmid:6382974
|
Hechtman HB et al. |
Role of humoral mediators in adult respiratory distress syndrome. |
1984 |
Chest |
pmid:6383742
|
Kelton JG et al. |
The detection of a platelet-agglutinating factor in thrombotic thrombocytopenic purpura. |
1984 |
Ann. Intern. Med. |
pmid:6333196
|
Bussolino F et al. |
Release of platelet-activating factor (PAF)-like material from human lymphoid cell lines. |
1984 |
Exp. Hematol. |
pmid:6333353
|
Wodzinowska B and Krajewski T |
[Role of blood platelets and their membrane in the process of hemostasis]. |
1984 Jan-Feb |
Postepy Hig Med Dosw |
pmid:6093087
|
Vemulapalli S et al. |
Cardiovascular and renal action of platelet-activating factor in anesthetized dogs. |
1984 Jul-Aug |
Hypertension |
pmid:6378787
|
Cox CP et al. |
VIP elevates platelet cyclic AMP (cAMP) levels and inhibits in vitro platelet activation induced by platelet-activating factor (PAF). |
1984 Mar-Apr |
Peptides |
pmid:6206481
|
Billah MM et al. |
Platelet-activating factor metabolism in human amnion and the responses of this tissue to extracellular platelet-activating factor. |
1985 |
Prostaglandins |
pmid:3936121
|
Maes L et al. |
In vivo arterial platelet-vessel wall interaction and thrombosis: induction, on-line registration and ultrastructural control. |
1985 |
Adv. Exp. Med. Biol. |
pmid:3832867
|
Valone FH |
Inhibition of binding of the platelet-activating factor AGEPC to platelets by the AGEPC analog rac-3-(N-n-octadecylcarbamoyloxy)-2-methoxypropyl 2-thiazolioethyl phosphate (CV-3988). |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:3970703
|
Camussi G and Brentjens JR |
Inhalation of horseradish peroxidase by rabbits with specific IgE antibodies results in release into the circulation of platelet-activating factor and in lung lesions. |
1985 |
Clin. Immunol. Immunopathol. |
pmid:3971603
|
Ludwig JC et al. |
Modulation of platelet-activating factor (PAF) synthesis and release from human polymorphonuclear leukocytes (PMN): role of extracellular albumin. |
1985 |
Arch. Biochem. Biophys. |
pmid:4037794
|
Surles JR et al. |
Facile synthesis of platelet-activating factor and racemic analogues containing unsaturation in the sn-1-alkyl chain. |
1985 |
J. Med. Chem. |
pmid:4038418
|
Hanahan DJ et al. |
A novel approach to structure proof of glyceryl ether-containing glycerophospholipids. Base-catalyzed methanolysis of platelet-activating factor (AGEPC) at 60 degrees C. |
1985 |
J. Lipid Res. |
pmid:4067422
|
Pedersen AK and FitzGerald GA |
Cyclooxygenase inhibition, platelet function, and metabolite formation during chronic sulfinpyrazone dosing. |
1985 |
Clin. Pharmacol. Ther. |
pmid:3917387
|
Monnens L et al. |
Platelet aggregating factor in the epidemic form of hemolytic-uremic syndrome in childhood. |
1985 |
Clin. Nephrol. |
pmid:4042442
|
Pirotzky E et al. |
Vascular permeability induced by Paf-acether (platelet-activating factor) in the isolated perfused rat kidney. |
1985 |
Agents Actions |
pmid:4003192
|
Avdonin PV et al. |
[Mechanism of increase in Ca2+ level in platelet cytoplasm induced by aggregating factors]. |
1985 |
Biokhimiia |
pmid:3000463
|